APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro).
暂无分享,去创建一个
[1] B. Freedman,et al. Apolipoprotein L1 Gene Testing Comes of Age. , 2020, Kidney360.
[2] Nicholette D. Palmer,et al. APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale , 2019, Kidney international reports.
[3] B. Freedman,et al. Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation , 2020, Transplantation.
[4] C. Winkler,et al. Genetic Testing for APOL1 Genetic Variants in Clinical Practice: Finally Starting to Arrive. , 2019, Clinical journal of the American Society of Nephrology : CJASN.
[5] A. Iltis,et al. APOL1 Genetic Testing in Living Kidney Transplant Donors. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] S. Fullerton,et al. Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions , 2019, American Journal of Nephrology.
[7] S. Fullerton,et al. You Are Just Now Telling Us About This? African American Perspectives of Testing for Genetic Susceptibility to Kidney Disease. , 2019, Journal of the American Society of Nephrology : JASN.
[8] B. Freedman,et al. APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] A. Garg,et al. APOL1 Genotype and Renal Function of Black Living Donors. , 2018, Journal of the American Society of Nephrology : JASN.
[10] C. Lewis,et al. Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors , 2017, Annals of surgery.
[11] B. Freedman,et al. Apolipoprotein L1 Gene Effects on Kidney Transplantation. , 2017, Seminars in nephrology.
[12] A. Israni,et al. Effect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] Nicholette D. Palmer,et al. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors , 2016, Transplantation.
[14] B. Freedman,et al. Hypertension-attributed nephropathy: what's in a name? , 2016, Nature Reviews Nephrology.
[15] K. Skorecki,et al. Hypertension-misattributed kidney disease in African Americans. , 2013, Kidney international.
[16] C. Winkler,et al. Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.